Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
02 05 2023
Historique:
received: 12 03 2022
revised: 07 06 2022
accepted: 26 06 2022
medline: 4 5 2023
pubmed: 12 8 2022
entrez: 11 8 2022
Statut: ppublish

Résumé

Macrophages have a critical and dual role in post-ischaemic cardiac repair, as they can foster both tissue healing and damage. Multiple subsets of tissue resident and monocyte-derived macrophages coexist in the infarcted heart, but their precise identity, temporal dynamics, and the mechanisms regulating their acquisition of discrete states are not fully understood. To address this, we used multi-modal single-cell immune profiling, combined with targeted cell depletion and macrophage fate mapping, to precisely map monocyte/macrophage transitions after experimental myocardial infarction. We performed single-cell transcriptomic and cell-surface marker profiling of circulating and cardiac immune cells in mice challenged with acute myocardial infarction, and integrated single-cell transcriptomes obtained before and at 1, 3, 5, 7, and 11 days after infarction. Using complementary strategies of CCR2+ monocyte depletion and fate mapping of tissue resident macrophages, we determined the origin of cardiac macrophage populations. The macrophage landscape of the infarcted heart was dominated by monocyte-derived cells comprising two pro-inflammatory populations defined as Isg15hi and MHCII+Il1b+, alongside non-inflammatory Trem2hi cells. Trem2hi macrophages were observed in the ischaemic area, but not in the remote viable myocardium, and comprised two subpopulations sequentially populating the heart defined as Trem2hiSpp1hi monocyte-to-macrophage intermediates, and fully differentiated Trem2hiGdf15hi macrophages. Cardiac Trem2hi macrophages showed similarities to 'lipid-associated macrophages' found in mouse models of metabolic diseases and were observed in the human heart, indicating conserved features of this macrophage state across diseases and species. Ischaemic injury induced a shift of circulating Ly6Chi monocytes towards a Chil3hi state with granulocyte-like features, but the acquisition of the Trem2hi macrophage signature occurred in the ischaemic tissue. In vitro, macrophages acquired features of the Trem2hi signature following apoptotic-cell efferocytosis. Our work provides a comprehensive map of monocyte/macrophage transitions in the ischaemic heart, constituting a valuable resource for further investigating how these cells may be harnessed and modulated to promote post-ischaemic heart repair.

Identifiants

pubmed: 35950218
pii: 6660804
doi: 10.1093/cvr/cvac113
pmc: PMC10153424
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

772-785

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.

Déclaration de conflit d'intérêts

Conflict of interest: C.H. collaborates with Denali Therapeutics, participated on one advisory board meeting of Biogen, and received a speaker honorarium from Novartis and Roche. C.H. is chief advisor of ISAR Bioscience and a member of the advisory board of AviadoBio.

Références

Circ Res. 2020 Oct 9;127(9):e232-e249
pubmed: 32811295
Circ Res. 2018 Jun 8;122(12):1661-1674
pubmed: 29545365
Basic Res Cardiol. 2021 Oct 3;116(1):55
pubmed: 34601654
J Exp Med. 2012 Jan 16;209(1):123-37
pubmed: 22213805
Eur J Immunol. 2021 Jan;51(1):250-252
pubmed: 32761616
Circ Res. 2013 Sep 27;113(8):1004-12
pubmed: 23836795
Circ Res. 2014 May 9;114(10):1611-22
pubmed: 24625784
Nat Immunol. 2019 Jan;20(1):29-39
pubmed: 30538339
Curr Opin Immunol. 2021 Feb;68:54-63
pubmed: 33128959
J Am Coll Cardiol. 2019 Jun 18;73(23):2990-3002
pubmed: 31196457
Nat Immunol. 2015 Jul;16(7):718-28
pubmed: 26054720
Eur Heart J. 2018 Jan 1;39(1):60-69
pubmed: 28549109
Basic Res Cardiol. 2018 Jun 4;113(4):26
pubmed: 29868933
Sci Immunol. 2022 Jan 07;7(67):eabf7777
pubmed: 34995099
Nat Commun. 2012;3:1329
pubmed: 23271661
Cell. 2017 Jun 15;169(7):1276-1290.e17
pubmed: 28602351
PLoS One. 2012;7(5):e36814
pubmed: 22590615
Immunity. 2009 Aug 21;31(2):245-58
pubmed: 19646905
Cell Rep. 2021 Jan 12;34(2):108626
pubmed: 33440159
Circ Res. 2014 Jul 7;115(2):284-95
pubmed: 24786973
JACC Basic Transl Sci. 2020 Dec 09;5(12):1210-1224
pubmed: 33426377
Nat Med. 2017 Dec;23(12):1481-1487
pubmed: 29106401
Immunity. 2021 Sep 14;54(9):2057-2071.e6
pubmed: 34363749
Nat Methods. 2017 Sep;14(9):865-868
pubmed: 28759029
J Exp Med. 2007 Nov 26;204(12):3037-47
pubmed: 18025128
Nat Med. 2011 May;17(5):581-8
pubmed: 21516086
Cell Metab. 2019 Feb 5;29(2):443-456.e5
pubmed: 30595481
J Exp Med. 2014 Oct 20;211(11):2151-8
pubmed: 25245760
Nature. 2019 Nov;575(7783):512-518
pubmed: 31597160
Cell Death Dis. 2022 Jan 12;13(1):53
pubmed: 35022393
Front Cell Dev Biol. 2020 Dec 14;8:613116
pubmed: 33381508
Physiol Rev. 2018 Oct 1;98(4):2523-2569
pubmed: 30156496
Immunity. 2019 Feb 19;50(2):288-301
pubmed: 30784577
Circ Res. 2019 Jan 18;124(2):263-278
pubmed: 30582448
Neuron. 2020 Mar 4;105(5):837-854.e9
pubmed: 31902528
Science. 2020 Feb 14;367(6479):
pubmed: 31974159
Cell. 2022 Jan 20;185(2):379-396.e38
pubmed: 35021063
Biochem Pharmacol. 2018 Jul;153:159-167
pubmed: 29452096
Elife. 2020 Oct 16;9:
pubmed: 33063665
Front Immunol. 2014 Oct 27;5:533
pubmed: 25386179
Circ Res. 2010 Mar 5;106(4):796-808
pubmed: 20056917
Elife. 2019 Mar 26;8:
pubmed: 30912746
J Immunol. 2001 Apr 1;166(7):4697-704
pubmed: 11254730
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
Circ Res. 2005 Oct 28;97(9):922-7
pubmed: 16179587
Immunity. 2020 Jun 16;52(6):1039-1056.e9
pubmed: 32392463
Genome Biol. 2018 Dec 19;19(1):224
pubmed: 30567574
Immunity. 2017 Nov 21;47(5):890-902.e4
pubmed: 29166589
Nat Immunol. 2022 Feb;23(2):217-228
pubmed: 35102344
Sci Immunol. 2018 Oct 5;3(28):
pubmed: 30291130
Sci Immunol. 2020 Sep 25;5(51):
pubmed: 32978242
J Clin Invest. 2021 Mar 15;131(6):
pubmed: 33529176
Immunity. 2020 Sep 15;53(3):641-657.e14
pubmed: 32888418
Eur Heart J. 2015 Aug 1;36(29):1923-34
pubmed: 25982896
Science. 2019 Mar 15;363(6432):
pubmed: 30872492
Nat Neurosci. 2013 Nov;16(11):1618-26
pubmed: 24077561
Cell. 2019 Jul 25;178(3):686-698.e14
pubmed: 31257031

Auteurs

Giuseppe Rizzo (G)

Comprehensive Heart Failure Center, University Hospital Würzburg, Am Schwarzenberg 15, A15, 97078 Würzburg, Germany.
Institute of Experimental Biomedicine, University Hospital Würzburg, Josef-Schneider-Str. 2, D16, 97080 Würzburg, Germany.

Julius Gropper (J)

Comprehensive Heart Failure Center, University Hospital Würzburg, Am Schwarzenberg 15, A15, 97078 Würzburg, Germany.
Institute of Experimental Biomedicine, University Hospital Würzburg, Josef-Schneider-Str. 2, D16, 97080 Würzburg, Germany.

Marie Piollet (M)

Comprehensive Heart Failure Center, University Hospital Würzburg, Am Schwarzenberg 15, A15, 97078 Würzburg, Germany.
Institute of Experimental Biomedicine, University Hospital Würzburg, Josef-Schneider-Str. 2, D16, 97080 Würzburg, Germany.

Ehsan Vafadarnejad (E)

Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Josef-Schneider-Str. 2, D15, 97080 Würzburg, Germany.

Anna Rizakou (A)

Institute of Experimental Biomedicine, University Hospital Würzburg, Josef-Schneider-Str. 2, D16, 97080 Würzburg, Germany.

Sourish Reddy Bandi (SR)

Comprehensive Heart Failure Center, University Hospital Würzburg, Am Schwarzenberg 15, A15, 97078 Würzburg, Germany.
Institute of Experimental Biomedicine, University Hospital Würzburg, Josef-Schneider-Str. 2, D16, 97080 Würzburg, Germany.

Panagiota Arampatzi (P)

Core Unit Systems Medicine, University Hospital Würzburg, Josef-Schneider-Str. 2, D15, 97080 Würzburg, Germany.

Tobias Krammer (T)

Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Josef-Schneider-Str. 2, D15, 97080 Würzburg, Germany.

Nina DiFabion (N)

Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Josef-Schneider-Str. 2, D15, 97080 Würzburg, Germany.

Oliver Dietrich (O)

Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Josef-Schneider-Str. 2, D15, 97080 Würzburg, Germany.

Anahi-Paula Arias-Loza (AP)

Comprehensive Heart Failure Center, University Hospital Würzburg, Am Schwarzenberg 15, A15, 97078 Würzburg, Germany.

Marco Prinz (M)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Matthias Mack (M)

Department of Internal Medicine II, Nephrology, Franz-Josef-Strauss Allee 11, University Hospital Regensburg, 93053 Regensburg, Germany.

Kai Schlepckow (K)

German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany.

Christian Haass (C)

German Center for Neurodegenerative Diseases (DZNE) Munich, 81377 Munich, Germany.
Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-Universität München, 81377 Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany.

Jean-Sébastien Silvestre (JS)

Université de Paris, PARCC, INSERM, F-75015 Paris, France.

Alma Zernecke (A)

Institute of Experimental Biomedicine, University Hospital Würzburg, Josef-Schneider-Str. 2, D16, 97080 Würzburg, Germany.

Antoine-Emmanuel Saliba (AE)

Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center for Infection Research (HZI), Josef-Schneider-Str. 2, D15, 97080 Würzburg, Germany.

Clément Cochain (C)

Comprehensive Heart Failure Center, University Hospital Würzburg, Am Schwarzenberg 15, A15, 97078 Würzburg, Germany.
Institute of Experimental Biomedicine, University Hospital Würzburg, Josef-Schneider-Str. 2, D16, 97080 Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH